WHO expresses concern over new government-approved TB drug

By Teena Thacker
2 November, 2017

A top World Health Organization (WHO) official has flagged concerns over a new tuberculosis drug called delamanid—billed as the potential “wonder drug” solution to multi-drug resistant (MDR) TB—just as India prepares to roll it out as part of its programme to eradicate TB.

“Delamanid failed to show that it adds to efficacy of old WHO MDR TB regimen”, WHO’s director of the global tuberculosis programme Mario C. Raviglione tweeted earlier this week.

The tweet followed the release of Phase-III randomized control trial results by Otsuka Pharmaceutical at the 48th Union World Conference on Lung Health in October this year.

Read the full article here: http://www.livemint.com/Politics/Cyz8d2tR95PWAp9AdxWqyL/WHO-expresses-co...